Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ambarella Inc (AMBA) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

Ambarella IncTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Ambarella Inc vs Intuitive Surgical, Inc. — how do they compare? Ambarella Inc trades at $74.98 (market cap $3.39B), while Intuitive Surgical, Inc. trades at $408.5 (market cap $144.07B). The key difference: Intuitive Surgical, Inc. is far larger — about 42.5× Ambarella Inc's market cap, and Ambarella Inc is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals.

AMBAISRG
Market Cap
$3.39B$144.07B
Sector
TechnologyHealth
52-Week High
$95.51$592.85
52-Week Low
$48.65$397.68
Enterprise Value
$3.13B$139.55B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ambarella Inc

Ambarella (AMBA) trades at $77.30, down 1.38% on the day, with a bullish technical setup supported by moving averages and key resistance at $81. The company reported three consecutive quarterly EPS beats, with Q1 2027 earnings of $0.11 meeting estimates, while revenue grew 16.9% year-over-year to $100.4 million. A major catalyst is the $800+ million long-term edge AI agreement with Hanwha, signaling strong demand in physical AI markets. However, net income remains negative at -$117.13 million for 2025, though margins are improving.

Outlook: Wall Street is bullish with a $108.67 consensus price target (40% upside), driven by edge AI adoption and auto sector growth. Risks include persistent losses, competitive pressure from larger chipmakers, and execution challenges in scaling new AI contracts. The stock's valuation at 8.21x sales appears reasonable if revenue acceleration continues, but profitability remains key for sustained gains.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $406.78, down 1.16% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q1 2026 earnings of $2.50 EPS, beating estimates, with revenue reaching $10.06 billion in 2025 and net income margin at 28.15%. Analyst consensus is bullish with a $556.10 price target, though valuation ratios like P/E of 49.43 remain elevated. Recent news highlights Q2 2026 earnings anticipation on July 16 and ongoing adoption of da Vinci 5 systems.

Outlook is positive due to consistent earnings beats and robust revenue growth, but risks include high valuation sensitivity and competitive pressures. The stock offers long-term growth potential in robotic surgery, yet investors should monitor margin trends and quarterly results for sustained momentum amid market volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ambarella Inc

Ambarella is a semiconductor company specializing in low-power video compression and computer vision processors. Its chips power AI cameras for security, automotive safety, and robotics applications.

Read more on AMBA

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG